| Methotrexate |
20090471 |
Ebetrexat, Solution for injection, 20 mg/ml - 0.375 ml, -, Pack: 1 pre-filled syringe |
Ebewe Pharma GmbH. N.fg. KG,, Австрия |
Ebewe Pharma Ges.m.b.H. Nfg.KG, Mondseestrasse 11, A-4866 Unterach, Австрия; Salutas Pharma GmbH, Otto-vоn-Guericke-Alle 1, D-39179 Barleben, Германия |
17.39 |
3.48 |
20.87 |
6% |
1.04 |
18.43 |
3.69 |
22.12 |
18% |
3.13 |
21.56 |
4.31 |
25.87 |
корекционно решение НСР-6893/30.07.2015 |
НСР-6516/18.06.2015 |
04.07.2015 |
04.07.2015 |
Неактивен |
4007 |
| Methotrexate |
20090471 |
Ebetrexat, Solution for injection, 20 mg/ml - 0.5 ml, -, Pack: 1 pre-filled syringe |
Ebewe Pharma GmbH. N.fg. KG,, Австрия |
Ebewe Pharma Ges.m.b.H. Nfg.KG, Mondseestrasse 11, A-4866 Unterach, Австрия; Salutas Pharma GmbH, Otto-vоn-Guericke-Alle 1, D-39179 Barleben, Германия |
20.05 |
4.01 |
24.06 |
6% |
1.2 |
21.25 |
4.25 |
25.5 |
18% |
3.61 |
24.86 |
4.97 |
29.83 |
|
НСР-6515/18.06.2015 |
04.07.2015 |
04.07.2015 |
Неактивен |
4008 |
| Oseltamivir |
EU/1/14/915/005 |
Ebilfumin, Capsule, hard, 75, mg, Pack: 10 |
Actavis Group PTC ehf., Исландия |
Actavis ehf, Исландия |
19.26 |
3.85 |
23.11 |
6% |
1.16 |
20.42 |
4.08 |
24.5 |
18% |
3.47 |
23.89 |
4.78 |
28.67 |
|
НСР-4273/05.08.2014; НСР-13055/23.06.2017 г. |
20.08.2014 |
02.08.2017 |
Заличен |
3072 |
| Oseltamivir |
EU/1/14/915/005 |
Ebilfumin, Capsule, hard, 75, mg, Pack: 10 |
Actavis Group PTC ehf., Исландия |
Actavis ehf, Исландия |
19.26 |
3.85 |
23.11 |
6% |
1.16 |
20.42 |
4.08 |
24.5 |
18% |
3.47 |
23.89 |
4.78 |
28.67 |
|
НСР-4273/05.08.2014 |
20.08.2014 |
20.08.2014 |
Неактивен |
3072 |
| Anidulafungin |
EU/1/07/416/002 |
ECALTA, Powder for concentrate for solution for infusion, 100, mg, Pack: 1 |
Pfizer Europe MA EEIG, Белгия |
Pfizer Manufacturing Belgium NV Rijksweg 12 2870 Puurs, Белгия |
352.64 |
70.53 |
423.17 |
4% |
10 |
362.64 |
72.53 |
435.17 |
16% |
25 |
387.64 |
77.53 |
465.17 |
Промяна на обстоятелствата НСР-17315/22.11.2018 |
НСР-8985/14.04.2016.; НСР-11277/22.12.2016; НСР-19837/ 20.09.2019 |
05.10.2019 |
02.11.2019 |
Активен |
3525 |
| Anidulafungin |
EU/1/07/416/002 |
ECALTA, Powder for concentrate for solution for infusion, 100, mg, Pack: 1 |
Pfizer Europe MA EEIG, Белгия |
Pfizer Manufacturing Belgium NV Rijksweg 12 2870 Puurs, Белгия |
596.2 |
119.24 |
715.44 |
4% |
10 |
606.2 |
121.24 |
727.44 |
16% |
25 |
631.2 |
126.24 |
757.44 |
Промяна на обстоятелствата НСР-17315/22.11.2018 |
НСР-8985/14.04.2016.; НСР-11277/22.12.2016 |
07.01.2017 |
02.01.2019 |
Неактивен |
3525 |
| Anidulafungin |
EU/1/07/416/002 |
ECALTA, Powder for concentrate for solution for infusion, 100, mg, Pack: 1 |
Pfizer Limited, Обединено Кралство |
Pfizer Manufacturing Belgium NV Rijksweg 12 2870 Puurs, Белгия |
596.2 |
119.24 |
715.44 |
4% |
10 |
606.2 |
121.24 |
727.44 |
16% |
25 |
631.2 |
126.24 |
757.44 |
|
НСР-8985/14.04.2016.; НСР-11277/22.12.2016 |
07.01.2017 |
02.02.2017 |
Неактивен |
3525 |
| Anidulafungin |
EU/1/07/416/002 |
ECALTA, Powder for concentrate for solution for infusion, 100, mg, Pack: 1 |
Pfizer Limited, Обединено Кралство |
Pfizer Manufacturing Belgium NV Rijksweg 12 2870 Puurs, Белгия |
622.09 |
124.42 |
746.51 |
4% |
10 |
632.09 |
126.42 |
758.51 |
16% |
25 |
657.09 |
131.42 |
788.51 |
|
НСР-8985/14.04.2016. |
30.04.2016 |
30.04.2016 |
Неактивен |
3525 |
| Anidulafungin |
EU/1/07/416/002 |
ECALTA, Powder for concentrate for solution for infusion, 100, mg, Pack: 1 |
Pfizer Limited, Обединено Кралство |
Pfizer Manufacturing Belgium NV Rijksweg 12 2870 Puurs, Белгия |
622.09 |
124.42 |
746.51 |
4% |
10 |
632.09 |
126.42 |
758.51 |
16% |
25 |
657.09 |
131.42 |
788.51 |
|
НСР-8985/14.04.2016. |
30.04.2016 |
30.04.2016 |
Неактивен |
3525 |
| Anidulafungin |
EU/1/07/416/002 |
ECALTA, Powder for concentrate for solution for infusion, 100, mg, Pack: 1 |
Pfizer Limited, Обединено Кралство |
Pfizer Manufacturing Belgium NV Rijksweg 12 2870 Puurs, Белгия |
627.51 |
125.5 |
753.01 |
4% |
10 |
637.51 |
127.5 |
765.01 |
16% |
25 |
662.51 |
132.5 |
795.01 |
|
НСР-5513/29.01.2015 |
12.02.2015 |
12.02.2015 |
Неактивен |
3525 |
| Anidulafungin |
EU/1/07/416/001 |
ECALTA, -, 100, mg, Pack: 1 |
Pfizer Limited, Обединено Кралство |
Pfizer Manufacturing Belgium NV,
Rijksweg 12, 2870 Puurs, Belgium |
650.35 |
130.07 |
780.42 |
4% |
10 |
660.35 |
132.07 |
792.42 |
16% |
25 |
685.35 |
137.07 |
822.42 |
корекционно решение НСР-5221/08.12.2014 (допуска предварително изпълнение); Цената се заличава с решение НСР-5811/12.03.2015 ( в сила от 02.04.2015) |
НСР-4874/17.10.2014 |
08.12.2014 |
08.12.2014 |
Заличен |
3383 |
| Anidulafungin |
EU/1/07/416/001 |
ECALTA, -, 100, mg, Pack: 1 |
Pfizer Limited, Обединено Кралство |
Pfizer Manufacturing Belgium NV,
Rijksweg 12, 2870 Puurs, Belgium |
655.95 |
131.19 |
787.14 |
4% |
10 |
665.95 |
133.19 |
799.14 |
16% |
25 |
690.95 |
138.19 |
829.14 |
|
НСР-2221/20.12.2013 |
04.01.2014 |
04.01.2014 |
Неактивен |
3383 |
| Anidulafungin |
EU/1/07/416/001 |
ECALTA, -, 100, mg, Pack: 1 |
Pfizer Limited, Обединено Кралство |
Pfizer Manufacturing Belgium NV,
Rijksweg 12, 2870 Puurs, Belgium |
684.54 |
136.91 |
821.45 |
4% |
10 |
694.54 |
138.91 |
833.45 |
16% |
25 |
719.54 |
143.91 |
863.45 |
|
КЦ-575/23.02.2009 |
10.03.2009 |
10.03.2009 |
Неактивен |
3383 |
| Capecitabine |
EU/1/12/763/005 |
Ecansya, Film coated tablet, 150, mg, Pack: 60 |
KRKA, d.d., Словения |
Accord Healthcare Limited, Обединено кралство; Pharmacare Premium Limited, Малта; KRKA, d.d., Словения |
21.08 |
4.22 |
25.3 |
6% |
1.26 |
22.34 |
4.47 |
26.81 |
18% |
3.79 |
26.13 |
5.23 |
31.36 |
|
НСР-7850/15.01.2016.; НСР-15919/15.06.2018 |
02.07.2018 |
02.07.2018 |
Заличен |
3270 |
| Capecitabine |
EU/1/12/763/005 blister (PVC/PVdC/alu) |
Ecansya, Film coated tablet, 150, mg, Pack: 60 |
KRKA, d.d., Словения |
Accord Healthcare Limited, Обединено кралство; Pharmacare Premium Limited, Малта; KRKA, d.d., Словения |
21.08 |
4.22 |
25.3 |
6% |
1.26 |
22.34 |
4.47 |
26.81 |
18% |
3.79 |
26.13 |
5.23 |
31.36 |
|
НСР-7850/15.01.2016. |
02.02.2016 |
02.02.2016 |
Неактивен |
3270 |
| Capecitabine |
EU/1/12/763/005 blister (PVC/PVdC/alu) |
Ecansya, Film coated tablet, 150, mg, Pack: 60 |
KRKA, d.d., Словения |
Accord Healthcare Limited, Обединено кралство; Pharmacare Premium Limited, Малта; KRKA, d.d., Словения |
37.12 |
7.42 |
44.54 |
4% |
1.48 |
38.6 |
7.72 |
46.32 |
16% |
5.94 |
44.54 |
8.91 |
53.45 |
|
НСР-4881/17.10.2014 |
03.11.2014 |
03.11.2014 |
Неактивен |
3270 |
| Capecitabine |
EU/1/12/763/016 |
Ecansya, Film coated tablet, 500, mg, Pack: 30 |
KRKA, d.d., Словения |
Accord Healthcare Limited, Обединено кралство; Pharmacare Premium Limited, Малта; KRKA, d.d., Словения |
61.59 |
12.32 |
73.91 |
4% |
2.46 |
64.05 |
12.81 |
76.86 |
16% |
9.85 |
73.9 |
14.78 |
88.68 |
|
НСР-4881/17.10.2014; НСР-15919/15.06.2018 |
02.07.2018 |
02.07.2018 |
Заличен |
3269 |
| Capecitabine |
EU/1/12/763/016 blister (PVC/PVdC/alu) |
Ecansya, Film coated tablet, 500, mg, Pack: 30 |
KRKA, d.d., Словения |
Accord Healthcare Limited, Обединено кралство; Pharmacare Premium Limited, Малта; KRKA, d.d., Словения |
61.59 |
12.32 |
73.91 |
4% |
2.46 |
64.05 |
12.81 |
76.86 |
16% |
9.85 |
73.9 |
14.78 |
88.68 |
|
НСР-4881/17.10.2014 |
03.11.2014 |
03.11.2014 |
Неактивен |
3269 |
| Capecitabine |
EU/1/12/763/004 |
Ecansya, Film coated tablet, 150, mg, Pack: 30 |
KRKA, d.d., Словения |
Accord Healthcare Limited, Обединено кралство; Pharmacare Premium Limited, Малта; KRKA, d.d., Словения |
18.56 |
3.71 |
22.27 |
6% |
1.11 |
19.67 |
3.93 |
23.6 |
18% |
3.34 |
23.01 |
4.6 |
27.61 |
|
НСР-4881/17.10.2014; НСР-15919/15.06.2018 |
02.07.2018 |
02.07.2018 |
Заличен |
3268 |
| Capecitabine |
EU/1/12/763/004 blister (PVC/PVdC/alu) |
Ecansya, Film coated tablet, 150, mg, Pack: 30 |
KRKA, d.d., Словения |
Accord Healthcare Limited, Обединено кралство; Pharmacare Premium Limited, Малта; KRKA, d.d., Словения |
18.56 |
3.71 |
22.27 |
6% |
1.11 |
19.67 |
3.93 |
23.6 |
18% |
3.34 |
23.01 |
4.6 |
27.61 |
|
НСР-4881/17.10.2014 |
03.11.2014 |
03.11.2014 |
Неактивен |
3268 |
| Capecitabine |
EU/1/12/763/018 blister (PVC/PVdC/alu) |
Ecansya, Film coated tablet, 500, mg, Pack: 120 |
KRKA, d.d., Словения |
Accord Healthcare Limited, Обединено кралство; Pharmacare Premium Limited, Малта; KRKA, d.d., Словения |
89.03 |
17.81 |
106.84 |
4% |
3.56 |
92.59 |
18.52 |
111.11 |
16% |
14.24 |
106.83 |
21.37 |
128.2 |
|
НСР-7850/15.01.2016. |
02.02.2016 |
02.02.2016 |
Активен |
3267 |
| Capecitabine |
EU/1/12/763/018 blister (PVC/PVdC/alu) |
Ecansya, Film coated tablet, 500, mg, Pack: 120 |
KRKA, d.d., Словения |
Accord Healthcare Limited, Обединено кралство; Pharmacare Premium Limited, Малта; KRKA, d.d., Словения |
246.34 |
49.27 |
295.61 |
4% |
9.85 |
256.19 |
51.24 |
307.43 |
16% |
25 |
281.19 |
56.24 |
337.43 |
|
НСР-4881/17.10.2014 |
03.11.2014 |
03.11.2014 |
Неактивен |
3267 |
| Epirubicin |
II-14081/25.07.2011 |
Ecclepia, Solution for injection, 2 mg/ml - 25 ml, mg, Pack: 1 |
Ромастру Трейдинг ЕООД, България |
Genepharm S.A., Гърция |
44.12 |
8.82 |
52.94 |
4% |
1.76 |
45.88 |
9.18 |
55.06 |
16% |
7.06 |
52.94 |
10.59 |
63.53 |
|
НСР-6165/08.05.2015; НСР-9127/27.04.2016 |
02.06.2016 |
02.06.2016 |
Заличен |
3923 |
| Epirubicin |
II-14081/25.07.2011 |
Ecclepia, Solution for injection, 2 mg/ml - 25 ml, mg, Pack: 1 |
Ромастру Трейдинг ЕООД, България |
Genepharm S.A., Гърция |
44.12 |
8.82 |
52.94 |
4% |
1.76 |
45.88 |
9.18 |
55.06 |
16% |
7.06 |
52.94 |
10.59 |
63.53 |
|
НСР-6165/08.05.2015 |
25.05.2015 |
25.05.2015 |
Неактивен |
3923 |
| Epirubicin |
II-14081/25.07.2011 |
Ecclepia, Solution for injection, 2 mg/ml - 50 ml, mg, Pack: 1 |
Ромастру Трейдинг ЕООД, България |
Genepharm S.A., Гърция |
106.59 |
21.32 |
127.91 |
4% |
4.26 |
110.85 |
22.17 |
133.02 |
16% |
17.05 |
127.9 |
25.58 |
153.48 |
|
НСР-2550/24.01.2014; НСР-9148/27.04.2016 |
02.06.2016 |
02.06.2016 |
Заличен |
2456 |